YBL083C Antibody

Shipped with Ice Packs
In Stock

Description

Lack of Direct References

  • None of the search results explicitly mention an antibody targeting a protein encoded by this gene.

  • Antibody databases from the Antibody Society ( ) and regulatory agencies (FDA, NIH) list over 100 approved therapeutic antibodies, but none correspond to YBL083C.

Potential Contexts for YBL083C

If "YBL083C Antibody" refers to a research reagent:

  • Yeast protein studies: YBL083C encodes a protein involved in ribosome biogenesis in yeast. Antibodies against such proteins are typically used in basic research but are not widely commercialized.

  • Unconventional nomenclature: The name may represent an internal identifier from a specific study or vendor not indexed in public databases.

Recommendations for Further Research

To obtain information on "YBL083C Antibody":

  1. Verify nomenclature: Confirm whether "YBL083C" refers to a gene, protein, or a proprietary identifier.

  2. Consult specialized databases:

    • UniProt: Search for protein-specific antibodies (e.g., UniProt entry for YBL083C).

    • CiteAb: A search engine for research antibodies.

    • Antibody Registry: Global database of antibody identifiers.

  3. Contact vendors: Reach out to antibody suppliers (e.g., Abcam, Thermo Fisher) for custom or discontinued products.

Related Antibody Research Insights

While "YBL083C Antibody" is not documented in the provided sources, advances in antibody development include:

TechnologyApplicationExample Antibodies
Bispecific antibodies Cancer immunotherapy, autoimmune diseasesBlinatumomab, Amivantamab
Fc-engineered antibodies Enhanced effector functionsMargetuximab, Faricimab
Recombinant antibodies Improved specificity and reproducibilityYCharOS-validated antibodies

Key Challenges in Antibody Research

  • Specificity validation: Up to 75% of commercial antibodies fail in reproducibility tests, highlighting the need for rigorous validation (e.g., knockout cell lines) .

  • Naming conventions: Non-standard identifiers (e.g., internal codes) complicate tracking and accessibility.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YBL083C antibody; YBL0719 antibody; Putative uncharacterized protein YBL083C antibody
Target Names
YBL083C
Uniprot No.

Q&A

What is YBL083C and why is it studied in yeast research?

YBL083C is a gene in Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as baker's yeast. As part of the S. cerevisiae genome, YBL083C is studied to understand fundamental cellular processes in eukaryotes. The protein encoded by this gene can be detected using specific antibodies raised against recombinant YBL083C protein. While the exact function of YBL083C in the yeast stress response remains incompletely characterized, its study contributes to our understanding of yeast genetics and protein function. YBL083C is frequently included in molecular barcoded yeast knockout (YKO) collections, which are valuable tools for large-scale genomic analyses .

What applications are most suitable for YBL083C antibodies?

YBL083C antibodies are primarily utilized in enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications to detect and quantify the target protein in yeast samples. These applications allow researchers to investigate protein expression levels, post-translational modifications, and protein-protein interactions involving YBL083C. The antibody can be employed in experiments where precise identification of the antigen is required, particularly in studies examining yeast genetic knockouts or gene expression under various conditions . When designing experiments, researchers should consider that most commercially available YBL083C antibodies are polyclonal and raised in rabbits, which affects experimental design considerations for secondary antibody selection.

How should YBL083C antibodies be optimally stored and handled?

For optimal performance and longevity, YBL083C antibodies should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can significantly degrade antibody quality and performance. Commercial YBL083C antibodies are typically supplied in a liquid form containing 50% glycerol and 0.01M PBS (pH 7.4) with 0.03% Proclin 300 as a preservative . When handling the antibody for experiments, aliquoting into single-use volumes is strongly recommended to prevent repeated freeze-thaw cycles. For short-term storage during experimental procedures, antibodies can be kept at 4°C for up to one week, but should be returned to -20°C or -80°C for longer-term storage.

What is the most effective validation approach for YBL083C antibodies?

The gold standard for validating YBL083C antibodies involves parallel testing with wildtype yeast strains and YBL083C knockout mutants. This approach, similar to those used in established antibody characterization initiatives like YCharOS, allows for unambiguous determination of antibody specificity . To implement this validation strategy, researchers should:

  • Obtain both wildtype Saccharomyces cerevisiae strain S288c and a corresponding YBL083C knockout strain

  • Prepare protein extracts from both strains under identical conditions

  • Run parallel Western blots or ELISAs with the YBL083C antibody

  • Confirm specificity by observing signal in wildtype samples and absence of signal in knockout samples

  • Document secondary antibody-only controls to rule out non-specific binding

This genetic validation approach provides definitive evidence of antibody specificity and should be conducted before embarking on large-scale experiments .

What are the recommended dilution ranges and incubation conditions for YBL083C antibodies?

The optimal working dilution for YBL083C antibodies varies by application and specific antibody lot. For Western blot applications, typical dilution ranges start at 1:1000 up to 1:5000, while ELISA may require different dilutions, generally in the range of 1:2000 to 1:10000. To determine the optimal dilution for your specific experimental setup, a dilution series should be tested. Incubation conditions generally follow standard protocols:

ApplicationRecommended Dilution RangePrimary Antibody IncubationSecondary Antibody Incubation
Western Blot1:1000 - 1:5000Overnight at 4°C or 1-2 hours at room temperature1 hour at room temperature
ELISA1:2000 - 1:100001-2 hours at room temperature1 hour at room temperature

These parameters should be optimized based on signal strength and background levels observed in preliminary experiments .

What controls are essential when working with YBL083C antibodies?

Robust experimental design for YBL083C antibody work requires several critical controls:

  • Genetic controls: Inclusion of YBL083C knockout strains alongside wildtype strains provides the strongest validation of antibody specificity .

  • Loading controls: For Western blots, proteins such as actin or GAPDH should be probed to ensure equal loading across samples.

  • Secondary antibody-only control: Omitting primary antibody but including secondary antibody helps identify non-specific secondary antibody binding.

  • Isotype control: Using an irrelevant antibody of the same isotype (IgG for YBL083C polyclonal antibodies) helps identify non-specific binding due to the antibody class rather than antigen specificity .

  • Cross-reactivity control: Testing the antibody against other yeast strains or species can help determine cross-reactivity profiles.

These controls collectively enhance data reliability and reproducibility, which is particularly important given the ongoing challenges with antibody validation in the research community .

How can weak or inconsistent YBL083C antibody signals be addressed?

When encountering weak or inconsistent signals with YBL083C antibodies, several methodological adjustments can improve results:

  • Protein extraction optimization: Enhance protein extraction by using mechanical disruption methods optimized for yeast cells, such as glass bead lysis or sonication, combined with protease inhibitors to prevent degradation.

  • Membrane blocking adjustment: Test different blocking agents (5% non-fat dry milk vs. 3-5% BSA) to determine which provides the optimal signal-to-noise ratio.

  • Signal enhancement: Consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity or switching to fluorescent-based detection systems.

  • Antibody concentration: Increase primary antibody concentration incrementally, while monitoring background levels.

  • Extended incubation: Extend primary antibody incubation time to overnight at 4°C if room temperature incubations yield weak signals.

  • Sample preparation: Ensure proteins are fully denatured prior to SDS-PAGE by heating samples at 95°C for 5 minutes in the presence of reducing agents .

What are potential cross-reactivity concerns with YBL083C antibodies?

Cross-reactivity can significantly impact experimental interpretation when working with YBL083C antibodies. Potential sources of cross-reactivity include:

  • Homologous proteins: YBL083C may share sequence homology with other yeast proteins, potentially leading to cross-reactivity. Protein BLAST searches should be performed to identify proteins with sequence similarity.

  • Non-specific binding: The polyclonal nature of many YBL083C antibodies means they contain a heterogeneous mixture of antibodies that may bind to epitopes shared with other proteins.

  • Post-translational modifications: Modified forms of YBL083C or other proteins may create epitopes that cross-react with the antibody.

To mitigate these concerns, researchers should:

  • Validate antibody specificity using knockout strains

  • Consider epitope-tagged YBL083C constructs as alternatives

  • Perform peptide competition assays to confirm specificity

  • Test antibodies against a panel of related yeast proteins .

How do different sample preparation methods affect YBL083C antibody performance?

Sample preparation significantly impacts YBL083C antibody performance across different applications:

For Western blot applications, consider these factors:

  • Protein extraction method: Mechanical disruption (glass beads or sonication) typically yields better results for yeast proteins compared to chemical lysis alone.

  • Buffer composition: RIPA buffer with protease inhibitors is recommended for most applications, but native conditions may require milder detergents.

  • Sample denaturation: Complete denaturation (95°C for 5 minutes with β-mercaptoethanol) is essential for exposing YBL083C epitopes.

For immunoprecipitation applications, consider:

  • Crosslinking: Mild crosslinking may preserve protein-protein interactions involving YBL083C.

  • Buffer stringency: Lower detergent concentrations (0.1-0.5% NP-40 or Triton X-100) help maintain protein interactions.

  • Antibody coupling: Pre-coupling antibodies to protein A/G beads can reduce background from heavy and light chains.

These methodological considerations should be optimized based on the specific research question being addressed .

How can YBL083C antibodies contribute to protein complex studies?

YBL083C antibodies can be valuable tools for investigating protein complexes through several advanced approaches:

  • Co-immunoprecipitation (Co-IP): YBL083C antibodies can be used to pull down the target protein along with its interaction partners. This approach allows researchers to identify novel protein-protein interactions involving YBL083C. The method is particularly powerful when combined with mass spectrometry for unbiased identification of binding partners.

  • Proximity labeling: By combining YBL083C antibodies with proximity labeling techniques (such as BioID or APEX2), researchers can identify proteins in close proximity to YBL083C in living cells, providing spatial information about protein organization.

  • Fusion protein approaches: Similar to the BTLA-HVEM complex study, researchers can create fusion proteins involving YBL083C to stabilize transient interactions and generate complex-specific antibodies that recognize the interface between YBL083C and its binding partners .

  • Sequential immunoprecipitation: This technique involves two rounds of immunoprecipitation using antibodies against YBL083C and a suspected interaction partner to confirm direct interactions versus membership in larger complexes .

What considerations are important when using YBL083C antibodies in yeast knockout studies?

When incorporating YBL083C antibodies into knockout studies, several methodological considerations are essential:

  • Strain verification: Prior to antibody use, verify the knockout strain by PCR-based barcode sequencing. As described in the literature, this typically involves:

    • Extracting genomic DNA using lithium acetate/SDS solution

    • Amplifying unique molecular barcodes using specific primers (e.g., forward: 5'-GATGTCCACGAGGTCTCT-3'; reverse: 5'-CGGTGTCGGTCTCGTAG-3')

    • Confirming strain identity through Sanger sequencing

  • Experimental controls: Include isogenic parent strains alongside knockout strains to ensure proper interpretation of antibody signals.

  • Complementation studies: Consider reintroducing YBL083C expression in knockout strains to confirm phenotype reversal and antibody specificity.

  • Reporter systems: As demonstrated in noncanonical amino acid incorporation studies, fluorescent reporter systems can be combined with knockout strains and antibody-based detection to enhance experimental readouts .

  • Data interpretation: Absence of signal in knockout strains should be interpreted carefully, as it could result from either antibody specificity or technical factors like inefficient protein extraction.

How can quantitative analysis be applied to YBL083C antibody data?

Quantitative analysis of YBL083C antibody data requires rigorous approaches to ensure reproducibility and statistical validity:

  • Western blot quantification: When quantifying Western blot bands, researchers should:

    • Use imaging systems with linear dynamic range

    • Include a concentration gradient of purified protein for standard curve generation

    • Normalize target protein signal to loading controls (e.g., GAPDH, actin)

    • Apply appropriate statistical tests to determine significance

  • Relative readthrough efficiency (RRE): In studies involving genetic knockouts and their effect on translation, metrics like RRE can be applied, where a value of 1 indicates wildtype efficiency and 0 indicates complete inhibition .

  • Multiple technical replicates: At least three independent experiments with technical replicates should be performed to ensure statistical robustness.

  • Flow cytometry analysis: When combining YBL083C antibody staining with flow cytometry, mean fluorescence intensity (MFI) provides a quantitative measure of protein expression, but requires appropriate gating strategies and controls.

  • Data visualization: Scatter plots comparing wildtype and knockout strains can effectively visualize differential expression, as demonstrated in studies comparing S288c and Σ1278b yeast strains .

How can YBL083C antibodies complement genomic screening approaches?

YBL083C antibodies can be integrated with advanced genomic screening methods to enhance experimental outputs:

What methodological approaches ensure reproducibility in YBL083C antibody experiments?

Ensuring reproducibility when working with YBL083C antibodies requires adherence to best practices developed by antibody validation initiatives:

  • Standardized protocols: Implementing standardized experimental protocols similar to those used by collaborative antibody characterization initiatives like YCharOS can significantly improve reproducibility. These protocols typically include:

    • Defined cell lysis procedures

    • Consistent protein quantification methods

    • Standardized antibody dilutions and incubation times

    • Uniform washing and detection procedures

  • Antibody validation matrix:

Validation MethodPurposeImplementation
Genetic validationConfirm specificityTest antibody in wildtype vs. YBL083C knockout strain
Immunoprecipitation-mass spectrometryVerify target bindingIdentify proteins pulled down by YBL083C antibody
Peptide competitionConfirm epitope specificityPre-incubate antibody with peptide antigen before use
Lot-to-lot testingEnsure consistencyCompare performance of different antibody lots
Cross-platform testingEvaluate versatilityTest antibody in multiple applications (WB, ELISA, IP)
  • Data repository submission: Consider depositing antibody characterization data in public repositories, following the model established by YCharOS and other initiatives that promote transparent antibody validation .

How can YBL083C antibodies be used to study protein complexes in different yeast strains?

Investigating protein complexes involving YBL083C across different yeast strains requires specialized approaches:

  • Strain-specific optimization: Different yeast strains may require modified lysis conditions to effectively extract YBL083C and associated proteins. Parameters to optimize include:

    • Cell wall disruption methods (enzymatic vs. mechanical)

    • Buffer composition and pH

    • Detergent type and concentration

    • Protease inhibitor cocktails

  • Comparative co-immunoprecipitation: When studying protein complexes across strains:

    • Normalize input material carefully based on total protein content

    • Consider tagged versions of YBL083C to enable standardized pulldown across strains

    • Use reciprocal immunoprecipitation to confirm interactions

    • Apply quantitative proteomics to identify strain-specific interaction differences

  • Fusion protein approaches: As demonstrated in studies of protein complexes like BTLA-HVEM, fusion protein approaches can stabilize transient interactions and enable generation of complex-specific antibodies. These approaches may be particularly valuable when studying YBL083C interactions that differ between strains .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.